These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3541314)

  • 1. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization.
    Martinelli GP; Horowitz C; Chiang K; Racelis D; Schanzer H
    Transplantation; 1987 Jan; 43(1):140-5. PubMed ID: 3541314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
    Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
    Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival.
    Martinelli GP; Knight RK; Kaplan S; Racelis D; Dikman SH; Schanzer H
    Transplantation; 1988 Jun; 45(6):1021-6. PubMed ID: 3260047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.
    Knight RJ; Polokoff EG; Martinelli GP
    Transplantation; 1994 Nov; 58(9):1014-20. PubMed ID: 7974728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.
    Tchervenkov JI; Epstein MD; Alexander JW; Schroeder TJ
    Transplantation; 1989 Jan; 47(1):177-81. PubMed ID: 2643225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW
    Transplantation; 1991 Sep; 52(3):545-9. PubMed ID: 1716800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine.
    Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA
    Transplantation; 1988 Sep; 46(3):352-8. PubMed ID: 2971279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
    Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ
    J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
    Levy AE; Alexander JW; Babcock GF
    Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine, fish oil, and donor-specific transfusions independently improve cardiac allograft survival in rats given subtherapeutic doses of cyclosporin.
    Alexander JW; Levy A; Custer D; Valente JF; Babcock G; Ogle CK; Schroeder TJ
    JPEN J Parenter Enteral Nutr; 1998; 22(3):152-5. PubMed ID: 9586793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
    Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
    Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat.
    Levy AE; Alexander JW
    Transplantation; 1996 Jul; 62(2):262-6. PubMed ID: 8755826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
    Levy AE; Alexander JW
    Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of heterotopic heart allograft survival by local delivery of continuous low-dose cyclosporine therapy.
    Stepkowski SM; Goto S; Ito T; Reynolds K; Didlake R; Kim EK; Kahan BD
    Transplantation; 1989 Jan; 47(1):17-23. PubMed ID: 2521407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between pancreas and heart allotransplantation after administration of donor-specific antigen and cyclosporine.
    Cooke JC; McBride JL; Schulak JA
    Transplantation; 1989 Jul; 48(1):15-9. PubMed ID: 2473549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.